Biopharmaceuticals are a unique class of compounds due to their extreme structural complexity. The current text puts together a variety of the state‐of‐the art approaches that use mass spectrometry to evaluate various aspects of biopharmaceutical products ranging from monitoring stress‐related structural changes to their quantitation in pharmacokinetic studies.
Gives an overview how mass spectrometry can be used to study biopharmaceuticals.
Explores the existing techniques, their limitations and potential pitfalls.
Contains numeorus examples of analysis of biopharmaceutical products.
